微信直播

ACS 2015|Matteo Donadon:意大利肝切除手术的情况

Published at: 2015年第1卷第S1期

周丽桃
关键词:

编者按:2015年美国外科年会(the American College of Surgeons Clinical Congress,以下简称 ACS 会议)于10月4日至10月8日在美国芝加哥 McCormick Place 隆重举行。在本次会议上,意大利 Humanitas 临床研究中心的 Matteo Donadon 医生作为团队代表在10月5日的肝胆胰专场展示了他们的最新研究“Methylprednisolone or N-Acetylcysteine in Hepatic Resections: Results from a Pilot, Double-blind, Randomized Clinical Trial”。会后,AME 编辑有幸邀请了 Matteo Donadon 医生接受采访。采访中,Matteo Donadon 医生与我们分享了意大利肝切除手术的情况以及他热衷于当一名外科医生的缘由。

采访问题

  1. Could you give a brief introduction of the status of hepatic resection in Italy?

  2. Over these years, have you witnessed any progress in hepatic resection? In your opinion, which one has the most influence?

  3. With all the experiences you have, what are the key factors to perform a successful hepatic resection?

  4. What are the common indications for hepatic resection? Which one has the best prognosis?

  5. What makes you become enthusiastic about being a surgeon? 

 

采访编辑|周丽桃,AME出版社科学编辑

视频编辑|施云彪,AME出版社视频编辑

ACS 2015 专题

doi:

10.3978/kysj.2014.1.1242
comments powered by Disqus

附件